By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Decibel Therapeutics 

1325 Boylston Street
Suite 500
Boston  Massachusetts  02215  U.S.A.
Phone: 617-370-8701 Fax: n/a


Decibel Therapeutics is a hearing company focused on discovering and developing new therapies to protect, repair and restore hearing. By combining recent innovations in hearing science with leading diagnostic tools, biological insights, modeling and therapeutic delivery techniques, Decibel is pioneering a comprehensive approach to define the underlying biological causes of hearing loss and develop a pipeline of breakthrough therapies targeted to specific indications and populations. Founded by the world’s preeminent experts in hearing loss, Decibel Therapeutics was launched in 2015 by Third Rock Ventures and is headquartered in Cambridge, Mass.




President and CEO: Steven Holtzman

CMO: Leslie Shinobu, M.D., Ph.D.

Vice President, Pharmacology: Ada Silos-Santiago, Ph.D.


October 15, 2015: $52 Million Series A From GlaxoSmithKline, SR One and Third Rock Ventures.


Key Statistics

Ownership: Private

Web Site: Decibel


Company News
CEOs Of Decibel And Ovid (OVID) Urge Peers To 'Stand Up To Trump' 8/24/2017 6:47:49 AM
Google (GOOG) Invests Undisclosed Sum Into Boston's Decibel And Its Hearing Loss R&D Program 7/6/2017 7:27:30 AM
Boston's Decibel Moves Into Fenway Neighborhood With New HQ 5/17/2017 6:54:58 AM
Decibel Therapeutics Release: Biotech Expands Leadership Team With World-Class Bioinformatics Scientist; Appoints Three New Members To Its Board Of Directors 1/18/2017 7:25:54 AM
The Next Generation: Top 20 Life Science Startups to Watch in 2017 1/3/2017 3:19:44 PM
What You Need to Know About Decibel Therapeutics 1/3/2017 3:16:04 PM
Decibel Therapeutics Assembles World-Class Scientific Advisory Board 11/1/2016 10:31:25 AM
Decibel Therapeutics Beefs Up Executive Team With a New CSO and Three VPs 9/7/2016 6:15:09 AM
Year-Old Startup Decibel Therapeutics Inks Lease for Huge New HQ in Boston 8/4/2016 5:51:09 AM
Former Biogen (BIIB) Exec to Head Decibel Therapeutics, Plans to Fill 20 Jobs This Year, 40 to 60 in 2017 7/13/2016 6:13:46 AM